Tag Archives: Bayer

Bayer and Evotec Forge Partnership for Next-Generation Cardiovascular Therapies

(IN BRIEF) Bayer and Evotec have updated their strategic collaboration to focus on developing precision treatments for cardiovascular diseases (CVDs). Leveraging Evotec’s expertise in disease modelling using human induced pluripotent stem cells (iPSCs), the collaboration aims to identify and validate … Read the full press release

Bayer Invests $250 Million in Berkeley Cell Therapy Plant for Parkinson’s Disease Treatment

(IN BRIEF) Bayer has invested $250 million in a new cell therapy production plant in Berkeley, California, USA. This investment aims to support the production of materials for clinical trials and potential commercial launches of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), an … Read the full press release

Bayer Invests EUR 220 Million in Future of Regenerative Agriculture and Crop Protection Innovation

(IN BRIEF) Bayer is making a significant investment of EUR 220 million in research and development (R&D) at its Monheim site in Germany, focusing on its Crop Protection business. This represents the company’s largest single investment in Crop Protection in … Read the full press release

Pairwise and Bayer Extend Collaboration to Develop Gene-Edited Short-Stature Corn for Smart Agriculture

(IN BRIEF) Pairwise and Bayer have entered into a new five-year, multi-million Dollar collaboration focusing on gene-edited short-stature corn. Building on their initial partnership for corn, soy, wheat, cotton, and canola, this collaboration aims to optimize and enhance gene-edited short-stature … Read the full press release

BlueRock Therapeutics and bit.bio Collaborate on iPSC-Derived T Cell Therapies for Autoimmune Disorders

(IN BRIEF) BlueRock Therapeutics and bit.bio have announced a collaboration and option agreement to discover and manufacture iPSC-derived regulatory T cells (Tregs) for therapeutic use. Tregs are crucial for immune system balance and controlling excessive immune reactions, making them potential … Read the full press release

AskBio Initiates Clinical Trial for Gene Therapy Targeting Limb-Girdle Muscular Dystrophy Type 2I/R9

(IN BRIEF) Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company owned by Bayer AG, has begun the Phase 1/Phase 2 LION-CS101 clinical trial for patients with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). The trial is evaluating AB-1003 (LION-101), an investigational … Read the full press release

Bayer and Acuitas Therapeutics Join Forces for Targeted Gene Editing Delivery

Not intended for U.S. and UK Media (IN BRIEF) Bayer AG has partnered with Acuitas Therapeutics, Inc. to enhance its gene therapy portfolio. Acuitas’ lipid nanoparticle (LNP) delivery technology will enable targeted and efficient delivery of gene editing RNA components … Read the full press release

Bayer and Cedilla Therapeutics Partner to Develop Targeted Cancer Therapies

Not intended UK Media (IN BRIEF) Bayer and Cedilla Therapeutics have entered into an exclusive license agreement to develop and commercialize Cedilla’s CyclinE1/CDK2 complex inhibitors for precision oncology. These inhibitors target oncogenic drivers and offer a unique method of action, … Read the full press release

Bayer awards grants and mentorship to innovative agriculture researchers

(IN BRIEF) Bayer has announced the recipients of its 2023 Grants4Ag program, which will provide funding and mentorship to researchers working on sustainability and biotechnology in agriculture. The program will award grants ranging from €5,000 to €15,000 and connect researchers … Read the full press release

Bayer ribadisce l’impegno in Ucraina con un investimento di 60 milioni di euro nella produzione di semi di mais

(NOTIZIA IN BREVE) Bayer, la società di scienze della vita, ha annunciato un investimento di 60 milioni di euro nel suo impianto di produzione di semi di mais a Pochuiky, in Ucraina, per rafforzare la sua attività di Crop Science … Read the full press release

Bayer reaffirms commitment to Ukraine with €60 million investment in corn seed production

(IN BRIEF) Bayer, the life sciences company, has announced a €60 million investment in its corn seed production facility in Pochuiky, Ukraine, to strengthen its Crop Science business and contribute to rebuilding the economy of the country. The investment includes … Read the full press release

Siemens pioneers digital data chain for efficient plant component data management

(IN BRIEF) Siemens has supplied Bayer’s Crop Science Division with pressure transmitters containing standardized ID links, enabling the transfer of digital documentation in real time to the ERP system used by the customer. The transmitters feature technology that complies with … Read the full press release

Bayer Aims to Play a Leading Role in Promoting Corporate Water Stewardship

(IN BRIEF) Bayer has launched a new water strategy at the UN 2023 Water Conference in New York, which aims to make water an integral part of its business decisions, investments, and supplier selection. The strategy reflects the company’s role … Read the full press release

Bayer y M2i Group unen fuerzas para ofrecer soluciones de protección de cultivos sostenibles y no tóxicas

(NOTICIA EN BREVE) Bayer y la empresa francesa M2i Group se unen para ofrecer soluciones de protección de cultivos basadas en feromonas a los productores de frutas y verduras de todo el mundo. Bayer se convertirá en distribuidor exclusivo de … Read the full press release

Bayer and M2i Group Join Forces to Offer Sustainable and Non-Toxic Crop Protection Solutions

(IN BRIEF) Bayer and French firm M2i Group team up to offer pheromone-based crop protection solutions to fruit and veggie growers globally. Bayer to become exclusive distributor of select M2i products aimed at Lepidoptera pests in crops such as tomatoes, … Read the full press release

Nuovi progressi nel trattamento del cancro alla prostata: Darolutamide sta per essere approvato nell’UE

Non destinato ai media statunitensi e britannici (NOTIZIA IN BREVE) Il comitato per i medicinali per uso umano dell’Agenzia europea per i medicinali ha raccomandato l’autorizzazione all’immissione in commercio nell’Unione europea di darolutamide, un inibitore orale del recettore degli androgeni, … Read the full press release

New Advancement in Prostate Cancer Treatment: Darolutamide Set to be Approved in EU

Not intended for U.S. and UK Media (IN BRIEF) The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended darolutamide, an oral androgen receptor inhibitor, for marketing authorization in the European Union as a treatment for patients … Read the full press release

Bayer: Viralgen Vector Core Licensed for Large-Scale recombinant adeno-associated virus (rAAV) Gene Therapy Production

(PRESS RELEASE) SAN SEBASTIAN, Spain, 9-Jan-2023 — /EuropaWire/ — Bayer (ETR: BAYN), a global enterprise with core competencies in the life science fields of healthcare and nutrition and and one of the largest pharmaceutical companies in the world, has announced … Read the full press release

Bayer: Viralgen Vector Core con licencia para la producción de terapia génica de virus adenoasociados recombinantes (rAAV) a gran escala

(COMUNICADO DE PRENSA) SAN SEBASTIAN, Spain, 9-Jan-2023 — /EuropaWire/ — Bayer (ETR: BAYN), una empresa global con competencias básicas en los campos de las ciencias biológicas de la salud y la nutrición y una de las compañías farmacéuticas más grandes … Read the full press release

Bayer ForwardFarm event to demonstrate how farmers can benefit from reducing their ecological footprint while also increasing their yields

(PRESS RELEASE) ROMMERSKIRCHEN, Germany, 17-Oct-2022 — /EuropaWire/ — Bayer, a global enterprise with core competencies in the life science fields of healthcare and nutrition, has announced the start of its Fields of Opportunity event on the Bayer ForwardFarm in Rommerskirchen, … Read the full press release

Événement Bayer ForwardFarm pour démontrer comment les agriculteurs peuvent bénéficier de la réduction de leur empreinte écologique tout en augmentant leurs rendements

(COMMUNIQUÉ DE PRESSE) ROMMERSKIRCHEN, Germany, 17-Oct-2022 — /EuropaWire/ — Bayer, une entreprise mondiale avec des compétences clés dans les domaines des sciences de la vie des soins de santé et nutrition, a annoncé le début de son événement Fields of … Read the full press release

La Better Life Farming Alliance, que apoya a los pequeños agricultores, se expande en América Latina con la apertura de su primera ubicación en Córdoba, México

(COMUNICADO DE PRENSA) MONHEIM, 17-Mar-2022 — /EuropaWire/ — Bayer, una empresa global con competencias básicas en los campos de las ciencias biológicas de la salud y nutrición, ha anunciado que Better Life Farming Alliance, una asociación a largo plazo de … Read the full press release

The Better Life Farming Alliance, a supporter of smallholder farmers, expands in Latin America with first location opened in Córdoba, Mexico

(PRESS RELEASE) MONHEIM, 17-Mar-2022 — /EuropaWire/ — Bayer, a global enterprise with core competencies in the life science fields of healthcare and nutrition, has announced that the Better Life Farming Alliance, a long-term partnership of Bayer, IFC (International Finance Corporation), … Read the full press release

Bayer supports the fight against coronavirus in China with medicines and financial aid

(PRESS RELEASE) LEVERKUSEN, 28-Jan-2020 — /EuropaWire/ — Bayer is supporting people affected by the novel coronavirus outbreak in China. The pharmaceutical company is contributing medicines and financial help worth of approximately EUR 1.5 million. The donations will be sent to … Read the full press release

Bayer names their new Information and Digital Transformation Chief

(PRESS RELEASE) LEVERKUSEN, 24-Jan-2020 — /EuropaWire/ — Pharmaceutical company, Bayer, appoints Bijoy Sagar as their new Chief Information and Digital Transformation Officer (CIDO). Sagar, 50, will take over the CIDO position effective in June 2020. Sagar will assume the said … Read the full press release

Hong Kong listed WuXi Biologics to operate Bayer’s final drug product manufacturing plants in Leverkusen, Germany

Plants in Leverkusen will be operated by WuXi Biologics and will serve as a back-up site for final product manufacturing of Kovaltry™

(PRESS RELEASE) LEVERKUSEN, 16-Jan-2020 — /EuropaWire/ —  Life science, health care and nutrition global enterprise Bayer announced that the leading global open-access biologics technology firm WuXi Biologics (WuXi Bio), listed in Hong Kong (stock code: 2269.HK), through its subsidiary in … Read the full press release

2nd Bayer International Beef Symposium: parasite control, bovine respiratory disease, reproduction, digital innovation and animal well-being

(PRESS RELEASE) MONHEIM, Germany & RIBEIRÃO PRETO, Brazil, 2-Apr-2019 — /EuropaWire/ — Bayer reports for over 220 cattle professionals having attended its 2nd Bayer International Beef Symposium. Key topics discussed on the event were parasite control, bovine respiratory disease, reproduction, … Read the full press release

Chief Digital Officers (CDOs) take on digital transformation in Capgemini Research Institute’s latest Digital Transformation Review

(PRESS RELEASE) PARIS, 12-Feb-2019 — /EuropaWire/ — The latest Digital Transformation Review by Capgemini Research Institute looks into what lessons can be learnt from the leaders in the digital transformation. The publication is titled “Taking digital transformation to the next level: Lessons from … Read the full press release

Bayer: Strong harvest results for farmers using Climate Corporation’s new predictive seed selection and placement technology for corn

(PRESS RELEASE) MONHEIM, 09-Jan-2019 — /EuropaWire/ — The Climate Corporation (Climate), a subsidiary of Bayer and the industry leader in bringing digital innovation to farmers, today announced strong harvest results for farmers using Seed Advisor, its new predictive seed selection and … Read the full press release

Bayer awarded Best Public Outreach Program for its Transparency in Crop Science Initiative at the 11th Agrow Awards

MONHEIM AM RHEIN, Germany, 16-Nov-2018 — /EuropaWire/ — Bayer has been awarded Best Public Outreach Program for its Transparency in Crop Science Initiative at the 11th Agrow Awards ceremony, held in London, United Kingdom on November 12. Bayer was selected as the … Read the full press release

STUDY: Bayer’s Intacta RR2 PRO™ soybeans technology helps farmers reduce greenhouse gas emissions and overall environmental impact in South America

MONHEIM AM RHEIN, Germany/ ST. LOUIS, MO, USA, 16-Nov-2018 — /EuropaWire/ — Results from a five-year peer-reviewed study on Intacta RR2 PRO™ soybeans planted in South America were recently published, indicating that this technology from Bayer helps farmers reduce greenhouse gas emissions … Read the full press release

BASF strengthens its market position in agricultural solutions with the closing of acquisition of businesses and assets from Bayer

Complements own crop protection, biotech and digital activities; marks entry into seeds, non-selective herbicides, nematicide seed treatments Creates new opportunities for innovation and growth About 4,500 experienced employees join Agricultural Solutions team Ludwigshafen, Germany, 06-Aug-2018 — /EuropaWire/ — BASF has … Read the full press release

Teenagers from Germany, India, Africa and the U.S. awarded scholarships from Bayer Science & Education Foundation

International exchange: Pupils from Germany, India, Africa and the U.S. taking part in two-week, hands-on seminar focusing on life science, medical health and food science topics / Bayer partnering with renowned Center for STEM Learning at University of Colorado in … Read the full press release

Registration now open for BayG.A.P. online training on Good Agricultural Practices

Free online course in English starts on May 28 2018. Registration open now Portuguese and Spanish version planned for second half of 2018 BayG.A.P. online training in Integrated Pest Management, residue management and pollinator health helps farmers comply with international … Read the full press release

GFK Healthcare study supported by Bayer polled adolescents on their attitudes toward sexuality and contraception

Not intended for U.S. and UK Media – GFK Healthcare study on ‘Youth and Contraception’ marks World Contraception Day 2017 Number of unplanned pregnancies remains high globally / Study supported by Bayer shows that adolescents want to be addressed as … Read the full press release

Bayer to commercialize Bayfolan™ Cobre and Bayfolan™ Aktivator for foliar uses in various crops worldwide

Proven amino acids enhance integrated crop management / Biostimulants Bayfolan™ Cobre and Bayfolan™ Aktivator for foliar uses / Products stimulate plant growth and improve resistance to stresses MONHEIM, 14-Aug-2017 — /EuropaWire/ — Bayer and SICIT 2000 S.p.A., Arzignano (Vicenza), Italy, the … Read the full press release

Bayer Science & Education Foundation awards €30,000 to Basel University Hospital neurologist

Dr. David Seiffge Doctor at Basel University Hospital honored for clinical work on management of non-vitamin K dependent oral anticoagulants in acute stroke patients LEVERKUSEN, 21-Feb-2017 — /EuropaWire/ — The third winner of the Bayer Thrombosis Research Award has been chosen. … Read the full press release

L’équipe française remporte le prix paneuropéen Farming by Satellite

Le lauréat du 3ème Prix Farming by Satellite visant à promouvoir le recours aux technologies satellitaires dans le domaine de l’agriculture, a été désigné le lundi 23 janvier à l’occasion de l’International Green Week de Berlin. La gagnante toutes catégories … Read the full press release

Bayer to acquire Monsanto for USD 128 per share

Realizes a shared vision of integrated agricultural offerings, delivering enhanced solutions for growers and creates a leading innovation engine for the next generation of farming / USD 128 per share in all-cash transaction, represents 44 percent premium to Monsanto shareholders … Read the full press release

Bayer disappointed in Monsanto’s decision to reject its increased all-cash offer of USD 125 per share

LEVERKUSEN, 22-Jul-2016 — /EuropaWire/ — Bayer said today that it is disappointed in Monsanto’s decision to reject its increased all-cash offer of USD 125 per share, which represents a 40 percent premium over Monsanto’s closing share price on May 9, 2016. … Read the full press release